BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Treatment
173 results:

  • 1. Utilization of broad- versus narrow-spectrum antibiotics for the treatment of outpatient community-acquired pneumonia among adults in the United States.
    Nickel KB; Durkin MJ; Olsen MA; Sahrmann JM; Neuner E; O'Neil CA; Butler AM;
    Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5779. PubMed ID: 38511244
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
    Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
    Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. UBE4B regulates p27 expression in A549 NSCLC cells through regulating the interaction of HuR and the p27 5' UTR.
    Kim H; Jung SY; Yun HH; Yoo K; Lee JS; Lee JH
    Biochem Biophys Res Commun; 2024 Feb; 695():149484. PubMed ID: 38211530
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Molecular Basis for Selectivity of the Cytotoxic Response of lung Adenocarcinoma Cells to Cold Atmospheric Plasma.
    Biryukov M; Semenov D; Kryachkova N; Polyakova A; Patrakova E; Troitskaya O; Milakhina E; Poletaeva J; Gugin P; Ryabchikova E; Zakrevsky D; Schweigert I; Koval O
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002354
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Discovery of (R)-4-(8-methoxy-2-methyl-1-(1-phenylethy)-1H-imidazo[4,5-c]quinnolin-7-yl)-3,5-dimethylisoxazole as a potent and selective BET inhibitor for treatment of acute myeloid leukemia (AML) guided by FEP calculation.
    Yu S; Zhang Y; Yang J; Xu H; Lan S; Zhao B; Luo M; Ma X; Zhang H; Wang S; Shen H; Zhang Y; Xu Y; Li R
    Eur J Med Chem; 2024 Jan; 263():115924. PubMed ID: 37992518
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Incorporation of doxorubicin and CoFe
    Bahmani E; Banihashem S; Shirinzad S; Bybordi S; Shikhi-Abadi PG; Jazi FS; Irani M
    Int J Pharm; 2024 Jan; 649():123618. PubMed ID: 37977290
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma.
    Ura A; Hayashi T; Komura K; Hosoya M; Takamochi K; Sato E; Saito S; Wakai S; Handa T; Saito T; Kato S; Suzuki K; Yao T;
    J Pathol Clin Res; 2024 Jan; 10(1):e350. PubMed ID: 37974379
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. brd4 Protein as a Target for lung cancer and Hematological cancer Therapy: A Review.
    Zhang M; Li Y; Zhang Z; Zhang X; Wang W; Song X; Zhang D
    Curr Drug Targets; 2023; 24(14):1079-1092. PubMed ID: 37846578
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Selective degradation of brd4 suppresses lung cancer cell proliferation using GSH-responsive PROTAC precursors.
    Fan H; Zhou Z; Yu D; Sun J; Wang L; Jia Y; Tian J; Mi W; Sun H
    Bioorg Chem; 2023 Nov; 140():106793. PubMed ID: 37683536
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
    JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
    Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/brd4 axis.
    Fu Y; Liu L; Wu H; Zheng Y; Zhan H; Li L
    Mol Cell Biochem; 2024 Mar; 479(3):553-566. PubMed ID: 37120495
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Inhalable Biomineralized Liposomes for Cyclic Ca
    Fu F; Wang W; Wu L; Wang W; Huang Z; Huang Y; Wu C; Pan X
    ACS Nano; 2023 Mar; 17(6):5486-5502. PubMed ID: 36883602
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. METTL16 promotes translation and lung tumorigenesis by sequestering cytoplasmic eIF4E2.
    Wang F; Zhang J; Lin X; Yang L; Zhou Q; Mi X; Li Q; Wang S; Li D; Liu XM; Zhou J
    Cell Rep; 2023 Mar; 42(3):112150. PubMed ID: 36840945
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Design, Synthesis, and Biological Evaluation of a Potent Dual EZH2-brd4 Inhibitor for the treatment of Some Solid Tumors.
    Huang N; Liao P; Zuo Y; Zhang L; Jiang R
    J Med Chem; 2023 Feb; 66(4):2646-2662. PubMed ID: 36774555
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficacy, Safety, and Health-Related Quality of Life With Camrelizumab Plus Pemetrexed and Carboplatin as First-Line treatment for Advanced Nonsquamous NSCLC With Brain Metastases (cap-BRAIN): A Multicenter, Open-Label, Single-Arm, Phase 2 Study.
    Hou X; Zhou C; Wu G; Lin W; Xie Z; Zhang H; Yi J; Peng Z; Yin L; Ma C; Chen L
    J Thorac Oncol; 2023 Jun; 18(6):769-779. PubMed ID: 36738928
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Chloroquine Enhances Death in lung Adenocarcinoma A549 Cells Exposed to Cold Atmospheric Plasma Jet.
    Patrakova E; Biryukov M; Troitskaya O; Gugin P; Milakhina E; Semenov D; Poletaeva J; Ryabchikova E; Novak D; Kryachkova N; Polyakova A; Zhilnikova M; Zakrevsky D; Schweigert I; Koval O
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672225
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Influence of Preservatives on Insulin in Postmortem Blood: Application to a Case of Insulin Aspart Suicide.
    Arbouche N; Macoin E; Raul JS; Kintz P
    J Anal Toxicol; 2023 Jan; 46(9):e300-e306. PubMed ID: 36472350
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Interstitial lung Abnormalities at CT: Subtypes, Clinical Significance, and Associations with lung cancer.
    Hata A; Hino T; Yanagawa M; Nishino M; Hida T; Hunninghake GM; Tomiyama N; Christiani DC; Hatabu H
    Radiographics; 2022; 42(7):1925-1939. PubMed ID: 36083805
    [No Abstract]    [Full Text] [Related]  

  • 19. Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patients.
    Cui W; Milner-Watts C; O'Sullivan H; Lyons H; Minchom A; Bhosle J; Davidson M; Yousaf N; Scott S; Faull I; Kushnir M; Nagy R; O'Brien M; Popat S
    Eur J Cancer; 2022 Aug; 171():44-54. PubMed ID: 35704974
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Design and Synthesis of Dual EZH2/brd4 Inhibitors to Target Solid Tumors.
    Guo Z; Sun Y; Liang L; Lu W; Luo B; Wu Z; Huo B; Hu Y; Huang P; Wu Q; Wen S
    J Med Chem; 2022 May; 65(9):6573-6592. PubMed ID: 35500243
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.